NFKB1 and nasopharyngeal carcinoma: JSH‐23, an NFκB inhibitor, inhibits the transcriptional activity of NFκB by suppressing the nuclear translocation of NFκB p65.[30] NPC cells were pretreated with an NFκB inhibitor (NFκBi) for 24 h and then treated with vinburnine and IR.